[ad_1]
According to the statement made by the Ministry, to the meeting; Scientists conducted coronavirus vaccine studies in Turkey, Turkish Institutes of Health Administration (TÜSEB) President Erhan Akdogan, Turkey Scientific and Technological Research Council (TUBITAK) joined President Hasan Mandal already ministry officials. Health Minister husband, the opening address of the meeting, “Turkey’s perspective in this room,” began. Turkey’s coronavirus vaccine trials in 14 different centers of Ministers, remembering her husband, she continued, “to evaluate the work done at this meeting, we will be in a rapid effort at the conclusion point,” she said.
‘SIGNIFICANT DISTANCE TAKEN IN THE CLINICAL AND PRECLINICAL PHASE’
Minister Koca stated that TÜSEB and TÜBİTAK called in the early days of the epidemic and that 14 projects among the applicants were approved and started their work, stating that significant progress was made in the preclinical and clinical stages during this period. Stating that the animal trials of 5 vaccines were completed at the point reached, Minister Koca also stated that human trials of two candidate vaccines developed at Kayseri Erciyes University and Ankara University will begin.
LABORATORY FOR LARGE ANIMAL STUDIES
Underlining that it is necessary to act quickly without compromising standards but without drowning in bureaucracy, Minister Koca continued his words as follows:
“Turkey Pharmaceuticals and our medical device organization (TİTCK) published last week preparing a vaccine guide. In this guide, in clinical trials before vaccine trials are done with details to be done. Work will continue on this sense. On the other hand, large animal studies will be carried out and the GLP characteristics will be taken firstly our laboratory accreditation process is completed. This is our laboratory, our hospital in Istanbul Mehmet Akif Ersoy, all vaccines, Turkish pharmaceuticals and medical devices will add a great force to the work. “
During the rest of the meeting, Minister Koca received detailed information from scientists from Erciyes, Marmara, Atatürk, Hacettepe, Yıldız Teknik, Ege, Ankara, Ortadoğu Teknik, Selçuk, Boğaziçi, Akdeniz and the Izmir Center for Biomedicine and Genome Universities. , who carried out vaccination studies. The scientists also shared their point of view on their projects, their needs and suggestions for solutions.
[ad_2]